Raffaella Di Micco, PhD

San Raffaele Telethon Institute for Gene Therapy, Milan


Raffaella Di Micco is currently a group leader at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) in Milan. She studied Medical Biotechnologies at University of Naples and obtained her PhD in Molecular Medicine from the European School of Molecular Medicine (SEMM) in Milan working on the mechanisms of oncogene-induced cellular senescence. After that, she moved to United States at the Department of Pathology of New York University (NYU) for a postdoctoral training on the role of epigenetics in stem cell identity and cancer. Since 2016 she established her own lab at SR-TIGET focusing on the interplay between DNA damage response (DDR) and chromatin biology in the context of stem cell aging and ex vivo gene therapy.

At Future Medicine 2017 she will talk about: “Artifical Nucleases in the hematopoietic compartment: understanding the biology for a better cellular product”